disease

cte

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about cte: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2Connections

13Hypotheses

25Analyses

1Outgoing

1Incoming

19Experiments

20Debates

No summary available yet.

View on Wiki →

No AI portrait yet

Wiki Pages (20)

Knowledge base pages for this entity

Pathway Diagram

flowchart TD
    CTE["CTE"] -->|"phosphorylates"| TAU["TAU"]
    TAU["TAU"] -->|"associated with"| NEURODEGENERATION["NEURODEGENERATION"]
    TAU["TAU"] -->|"activates"| NEURODEGENERATION["NEURODEGENERATION"]
    TAU["TAU"] -->|"associated with"| ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"]
    TAU["TAU"] -->|"associated with"| TAUOPATHY["TAUOPATHY"]
    style CTE fill:#006494,stroke:#333,color:#e0e0e0
    style TAU fill:#4a1a6b,stroke:#333,color:#e0e0e0
    style NEURODEGENERATION fill:#5d2900,stroke:#333,color:#e0e0e0
    style ALZHEIMER_S_DISEASE fill:#4a1a6b,stroke:#333,color:#e0e0e0
    style TAUOPATHY fill:#4a1a6b,stroke:#333,color:#e0e0e0

Outgoing (1)

Target	Relation	Type	Str
TAU	phosphorylates	entity	0.60

Incoming (1)

Source	Relation	Type	Str
APOE	co_associated_with	gene	0.30

Targeting Hypotheses (13)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Smartphone-Detected Motor Variability Correction	0.742	neurodegeneration	Digital biomarkers and AI-driven early d
TFAM overexpression creates mitochondrial donor-recipient gr	0.725	neurodegeneration	Mitochondrial transfer between astrocyte
Bacterial Curli Amyloid → Nucleation of α-Synuclein Misfoldi	0.720	neurodegeneration	What are the mechanisms by which gut mic
SCFA-Producing Bacterial Depletion → Loss of Neuroprotective	0.700	neurodegeneration	What are the mechanisms by which gut mic
Bacterial Tyramine–Induced DOPAL Accumulation in Enteric Neu	0.680	neurodegeneration	What are the mechanisms by which gut mic

Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro	0.642	neurodegeneration	What are the mechanisms by which gut mic
H4: Hyperconnected Hub Status Creates Proteostatic Traffic J	0.600	neurodegeneration	Entorhinal cortex layer II vulnerability
APOE4 Isoform Correction via Lipidation Enhancement as CTE R	0.552	neurodegeneration	What genetic risk factors predispose ind
H63D HFE Genotype-Guided Iron Chelation Therapy for Subset-S	0.550	-	Ferroptosis in ALS and motor neuron dise
APOE4 astrocytes fail to supply sufficient cholesterol to pa	0.500	neuroscience	APOE4-driven lipid metabolism dysregulat
TH-neuron-restricted RGS6 rescue to test cell-autonomous the	0.460	neurodegeneration	Does RGS6 upregulation or D2 autorecepto
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis	0.384	neurodegeneration	What are the mechanisms by which gut mic
Network-Directed Anti-Amyloid Immunotherapy via Transcranial	0.360	connectomics	Human connectome alterations in Alzheime

Mentioning Analyses (25)

Scientific analyses that reference this entity

How does Alectinib, a kinase inhibitor, achieve high-affinity binding to complem

neuroinflammation | 2026-04-16 | 5 hypotheses Top: 0.599

What are the precise temporal dynamics of astrocyte ketone production decline du

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.808

How does engineered C. butyricum cross the blood-brain barrier to directly bind

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.699

Why does PRKN-mediated mitophagy, typically protective, cause harmful mitochondr

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.455

What genetic risk factors predispose individuals to developing CTE following rep

neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.552

Experiments (19)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
IRI-AKI mouse model with mtROS inhibition	validation	ischemic acute kidney injury	0.900	0.00	IRI-AKI mice	proposed	N/A
mtROS effects on TFAM and mtDNA in HK2 cells	exploratory	acute kidney injury	0.900	0.00	HK2 cells	proposed	N/A
TFAM knockdown functional analysis	exploratory	acute kidney injury	0.850	0.00	HK2 cells	proposed	N/A
TFAM and mtDNA analysis in AKI patients	clinical	acute kidney injury	0.800	0.00	human patients	proposed	N/A
Alpha-Synuclein SAA Kinetics Study — Biological Staging Backbone for P	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
Computational Modeling of Alpha-Synuclein Propagation in PD	validation	Parkinson's Disease	0.400	0.50	human	proposed	$2,280,000
Alpha-Synuclein Seed Amplification Assay Validation	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$7,500,000
Antiviral Therapy Trial for Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
Combination Therapy Sequencing in Parkinson's Disease	validation	Parkinson's Disease	0.400	0.50	human	proposed	$2,280,000
Genetic Risk Modifiers in DLB Phenotype	clinical	Neurodegeneration	0.400	0.50	human	proposed	$7,500,000
DLB Treatment Response Biomarkers — Predicting Cholinesterase Inhibito	clinical	Neurodegeneration	0.400	0.50	human	proposed	$6,550,000
Mechanism: Selective Vulnerability of Dopaminergic Neurons in Parkinso	validation	Parkinson's Disease	0.400	0.50	human	proposed	$3,000,000
Selective Vulnerability of Dopaminergic Neurons — Mechanism and Protec	validation	Neurodegeneration	0.400	0.50	cell_line	proposed	$160,000
Endocannabinoid System Dysfunction Validation in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$6,550,000
s:** - Test MCU overexpression specifically in layer II neurons in hea	falsification	Neurodegeneration	0.400	0.50	mouse	proposed	$200,000
Proposed experiment from debate on Mitochondrial transfer between astr	falsification	Neurodegeneration	0.400	0.50	cell_line	proposed	$80,000
Exercise-BDNF-Mitophagy Biomarker Study in PD	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$6,550,000
Ferroptosis Validation in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$6,550,000
GLP-1 Agonist Neuroprotection Mechanism in PD	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$6,550,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Melatonin attenuates sepsis-induced acute kidney injury by promoting mitophagy t [PMID:37651673]	Deng Z, He M, Hu H, Zhang W, Zhang Y, Ge	Autophagy	2024	1
TFAM is an autophagy receptor that limits inflammation by binding to cytoplasmic [PMID:38783142]	Liu H, Zhen C, Xie J, Luo Z, Zeng L, Zha	Nat Cell Biol	2024	1
Mitochondrial-derived damage-associated molecular patterns amplify neuroinflamma [PMID:35233090]	Lin MM, Liu N, Qin ZH, Wang Y	Acta Pharmacol Sin	2022	1
Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic [PMID:33408785]	Zhao M, Wang Y, Li L, Liu S, Wang C, Yua	Theranostics	2021	1
Mitochondrial DNA copy number in human disease: the more the better? [PMID:33314045]	Filograna R, Mennuni M, Alsina D, Larsso	FEBS Lett	2021	1
Atremorine in Parkinson's disease: From dopaminergic neuroprotection to pharmaco [PMID:34106485]	Cacabelos R, Carrera I, Martínez O, Alej	Med Res Rev	2021	1
Mitochondrial DNA stress triggers autophagy-dependent ferroptotic death. [PMID:32186434]	Li C, Zhang Y, Liu J, Kang R, Klionsky D	Autophagy	2021	1
Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation [PMID:31120439]	Luo Z, Ahlers-Dannen KE, Spicer MM, Yang	JCI Insight	2019	1
Targeting alpha synuclein and amyloid beta by a multifunctional, brain-penetrant [PMID:31873106]	Yedlapudi D, Xu L, Luo D, Marsh GB, Todi	Sci Rep	2019	1
A systematic review and integrative approach to decode the common molecular link [PMID:28927418]	Guin D, Mishra MK, Talwar P, Rawat C, Ku	BMC Med Genomics	2017	1
Butyrate extends health and lifespan in mice with mitochondrial deficiency. [PMID:41826362]	["Gaband\u00e9-Rodr\u00edguez E", "G\u00	Nature communications	2026	0
Vav-iCre-Mediated Deletion of TFAM Is Not Recoverable and Is Consistent with Emb [PMID:41898789]	["Ghosh R", "Shakur E", "Yousefzadeh M"]	Genes	2026	0
The role of genetic factors in the occurrence of levodopa-induced motor complica [PMID:40632937]	["Radojevi\u0107 B", "Milovanovi\u0107 A	Neurological research	2026	0
NRIP1 co-activates nuclear translocated FOXO3 to upregulate TFAM expression and [PMID:41888517]	["Zha Y", "Huang H", "Liu Y", "Wan M", "	Cell death discovery	2026	0
miR-137-5p-Loaded Milk-Derived Small Extracellular Vesicles Modulate Oxidative S [PMID:41754992]	["G\u00f6n\u00fcll\u00fc S", "Ayd\u0131n	Pharmaceutics	2026	0
Ginseng stem and leaf saponins attenuates pulmonary fibrosis by regulating TFAM- [PMID:41911987]	Chen Y, Hu L, Fu Q, Chen H, Jiang Z, Li	Journal of ethnopharmacology	2026	0
Structural Analysis of Human LonP1 Protease Bound with the Native Substrate. [PMID:41900996]	Li M, Liu H, Zhang S, Gao Q, Li S, Wang	Life (Basel, Switzerland)	2026	0
Computational examination of magainin-I-KL mediated disruption of E. coli biofil [PMID:41724836]	Vinutha AS, Akshay S, Sree Agash SG, Cha	Archives of microbiology	2026	0
The cytoplasmic protein YedX is a potent inhibitor of CsgA amyloid assembly in E [PMID:41581877]	Gurnani B, Jain N	The Journal of biological chem	2026	0
Effect of (-)-Epicatechin on Mitochondrial Homeostasis in Skeletal Muscle of Fem [PMID:41900149]	Herrera-Cogco EC, Herrera-Meza S, Martín	Molecules (Basel, Switzerland)	2026	0

Debates (20)

Multi-agent debates referencing this entity

Investigate prion-like spreading of tau pathology through connected brain region

closed · Rounds: 4 · Score: 0.73 · 2026-04-22

Tau pathology spreads through synaptically connected brain regions in Alzheimer

closed · Rounds: 4 · Score: 0.78 · 2026-04-22

While single-cell sequencing reveals microglial heterogeneity across regions, ag

closed · Rounds: 4 · Score: 0.73 · 2026-04-22

The abstract identifies dystrophic microglia as senescent cells in aged brains b

closed · Rounds: 4 · Score: 0.79 · 2026-04-22

The abstract describes IBA1 low/negative microglia in individuals with liver dis

closed · Rounds: 4 · Score: 0.76 · 2026-04-21

The abstract mentions that pathological seeds have different characteristics and

closed · Rounds: 4 · Score: 0.65 · 2026-04-21

The abstract mentions that antibody discovery has improved understanding of myel

closed · Rounds: 4 · Score: 0.66 · 2026-04-21

The ASO therapeutic hypothesis assumes dilncRNAs have targetable conserved struc

closed · Rounds: 4 · Score: 0.69 · 2026-04-21

What are the mechanisms by which tau pathology spreads through connected brain r

closed · Rounds: 4 · Score: 0.50 · 2026-04-20

The abstract reports that Alectinib binds C1q with high affinity, but this is me

closed · Rounds: 4 · Score: 0.94 · 2026-04-16

Related Research

Hypotheses and analyses mentioning cte in their description or question text

Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cross-Seeding

Score: 0.642 · neurodegeneration · 2026-04-02

## Mechanistic Overview Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cross-Seeding starts from the claim tha

H4: Hyperconnected Hub Status Creates Proteostatic Traffic Jams

Score: 0.600 · neurodegeneration · 2026-04-22

## Mechanistic Overview H4: Hyperconnected Hub Status Creates Proteostatic Traffic Jams starts from the claim that modul

APOE4 Isoform Correction via Lipidation Enhancement as CTE Risk Mitigation

Score: 0.552 · neurodegeneration · 2026-04-14

## Mechanistic Overview APOE4 Isoform Correction via Lipidation Enhancement as CTE Risk Mitigation starts from the claim

H63D HFE Genotype-Guided Iron Chelation Therapy for Subset-Selected ALS Patients

Score: 0.550 · unknown disease · 2026-04-16

## Mechanistic Overview H63D HFE Genotype-Guided Iron Chelation Therapy for Subset-Selected ALS Patients starts from the

APOE4 astrocytes fail to supply sufficient cholesterol to parvalbumin interneuro

Score: 0.500 · neuroscience · 2026-04-22

## Mechanistic Overview APOE4 astrocytes fail to supply sufficient cholesterol to parvalbumin interneurons, causing pres

TH-neuron-restricted RGS6 rescue to test cell-autonomous therapeutic sufficiency

Score: 0.460 · neurodegeneration · 2026-04-25

Use dopaminergic-neuron-selective expression of RGS6 to distinguish true cell-autonomous rescue from broader circuit or

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis

Score: 0.384 · neurodegeneration · 2026-04-02

Engineered probiotic bacteria expressing tyrosine hydroxylase and aromatic L-amino acid decarboxylase could produce L-DO

Network-Directed Anti-Amyloid Immunotherapy via Transcranial Focused Ultrasound

Score: 0.360 · connectomics · 2026-04-25

Network-Directed Anti-Amyloid Immunotherapy via Transcranial Focused Ultrasound

cte

Understanding Entity Pages

Wiki Pages (20)

Spinal Cord Stimulation-Affected Neurons

Transcranial Direct Current Stimulation-Affected Neurons

Responsive Neurostimulation System-Affected Neurons

Peripheral Nerve Stimulation-Affected Neurons

Anti-CASPR2 Encephalitis-Affected Neurons

Chrononutrition and Time-Restricted Eating in Neurodegeneration

Prion-Like Propagation of Proteinopathies — Template-Directed Misfolding in Neurodegeneration

Parabacteroides goldsteinii Mitigation of Parkinsonism in LRRK2 Mice

PSP Tau Aggregate Morphology and Molecular Characteristics

Prion-Infected Neurons

DYNLT1 — Dynein Light Chain Tctex-Type 1

Focused Ultrasound-Affected Neurons

Vagus Nerve Stimulation-Affected Neurons

Anti-LGI1 Encephalitis-Affected Neurons

Anti-AMPAR Encephalitis-Affected Neurons

Phage Display and Directed Evolution for Tau Therapeutics

Motor Cortex Stimulation-Affected Neurons

The Cortical/Transitional Zone of the Amygdala is Affected Early in Neurodegenerative Diseases

Deep Brain Stimulation-Affected Neurons

Peripherally Restricted Cannabinoids for Neurodegeneration

Pathway Diagram

Outgoing (1)

Incoming (1)

Targeting Hypotheses (13)

Mentioning Analyses (25)

How does Alectinib, a kinase inhibitor, achieve high-affinity binding to complem

What are the precise temporal dynamics of astrocyte ketone production decline du

How does engineered C. butyricum cross the blood-brain barrier to directly bind

Why does PRKN-mediated mitophagy, typically protective, cause harmful mitochondr

What genetic risk factors predispose individuals to developing CTE following rep

Why do p300/CBP inhibitors reduce both AD incidence and clinically diagnosed TBI

What molecular mechanisms enable functional recovery and muscle re-innervation a

Why do TAM receptors protect against neuroinvasive viruses despite their known i

Why do TAM receptors protect against neuroinvasive viruses despite their known i

Why does PGC-1α overexpression paradoxically increase MPTP toxicity despite enha

Do SCFAs directly modulate α-synuclein aggregation in vivo at physiologically re

Do bacterial curli amyloids cross the blood-brain barrier to directly seed α-syn

What are the conserved secondary structures in dilncRNAs that enable selective t

What are the specific pathophysiological mechanisms underlying uncommon immune-m

What molecular mechanisms determine the conformational diversity and strain-like

What causes IBA1 low/negative microglia in liver disease and how does this affec

What molecular mechanisms drive microglial senescence and the transition to dyst

How do regional, age, and sex-dependent differences in microglial populations af

Trans-synaptic tau spreading and propagation mechanisms in AD

Investigate prion-like spreading of tau pathology through connected brain region

Tau propagation mechanisms and therapeutic interception points

Tau propagation mechanisms and therapeutic interception points

Extracellular vesicle biomarkers for early AD detection

Tau propagation mechanisms and therapeutic interception points

Tau propagation mechanisms and therapeutic interception points

Experiments (19)

Related Papers (20)

Debates (20)

Investigate prion-like spreading of tau pathology through connected brain region

Tau pathology spreads through synaptically connected brain regions in Alzheimer

While single-cell sequencing reveals microglial heterogeneity across regions, ag

The abstract identifies dystrophic microglia as senescent cells in aged brains b

The abstract describes IBA1 low/negative microglia in individuals with liver dis

The abstract mentions that pathological seeds have different characteristics and

The abstract mentions that antibody discovery has improved understanding of myel

The ASO therapeutic hypothesis assumes dilncRNAs have targetable conserved struc

What are the mechanisms by which tau pathology spreads through connected brain r

The abstract reports that Alectinib binds C1q with high affinity, but this is me

Related Research

Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cross-Seeding

H4: Hyperconnected Hub Status Creates Proteostatic Traffic Jams

APOE4 Isoform Correction via Lipidation Enhancement as CTE Risk Mitigation

H63D HFE Genotype-Guided Iron Chelation Therapy for Subset-Selected ALS Patients

APOE4 astrocytes fail to supply sufficient cholesterol to parvalbumin interneuro

TH-neuron-restricted RGS6 rescue to test cell-autonomous therapeutic sufficiency

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis

Network-Directed Anti-Amyloid Immunotherapy via Transcranial Focused Ultrasound